BUFFALO, N.Y., April 1, 2019 /PRNewswire/ — Circuit Clinical™ today announced a comprehensive partnership with University at Buffalo that powers the collection, storage and genetic sequencing of vast numbers of disease-targeted biospecimens to advance innovation in drug discovery.
“This unique partnership greatly expands Circuit Clinical’s capabilities in creating the medical and genomic datasets needed to develop the next generation of American medicines,” said Dr. Irfan Khan, CEO of Circuit Clinical. “The goal of these collections is to help the pharmaceutical industry identify important targets and promising therapies in the years ahead.”
The agreement allows Circuit Clinical to collect, store and process blood, tissue and bodily fluids for genomic sequencing and studying of the microbiome in a value-sharing model.
“With our network access to more than 1 million patients, this partnership allows Circuit Clinical to provide partners with robust data in a way that prioritizes patient empowerment, ownership, privacy, and transparency,” stated Dr. Khan.
The UB biorepository is a state-of-the-art facility located in the Clinical and Translational Science Institute and managed by the NYS Center of Excellence for Bioinformatics & Life Sciences overseen by executive director Dr. Norma Nowak. The biorepository program enables critical clinical science research and diagnostic development, as well as the advancement of precision medicine through deep annotation and “big data” integration.
“Circuit Clinical is the ideal partner to collaborate with, given their unique ability to identify and engage with patients interested in donating their biosamples and medical data to drive drug discovery at an early stage,” said Dr. Nowak.
If you are interested in learning more about how Circuit Clinical can provide personalized medicine datasets, please contact Rachael Pollinger at (716) 349-7664.
About Circuit Clinical
Circuit Clinical is an Integrated Research Organization, dedicated to empowering patients choosing clinical research as a care option and transforming the experience of finding and participating in clinical trials. For more information visit www.circuitclinical.com
About UB’s Assets for Life Sciences
UB’s Center of Excellence in Bioinformatics and Life Sciences (CBLS), Buffalo Institute for Genomics and Data Analytics (BIG), Center for Advanced Technology in Big Data and Health Sciences (UB CAT) and the Biorepository program are strategic assets for life sciences innovation and technology-based scientific discovery.
Contact: Rachael Pollinger, Circuit Clinical
Phone: (716) 349-7664
Email: rpollinger@circuitclinical.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/in-landmark-university-agreement-circuit-clinical-adds-personalized-medicine-capabilities-through-ubs-genomics–biorepository-program-300821921.html
SOURCE Circuit Clinical
Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75%…
Digital health platform offers FDA-approved treatments when appropriate and personalized care plans through licensed providers.New…
NSCEB is launching a 3-month tour of the booming U.S. biotechnology ecosystem RALEIGH, N.C., June…
MDP Completes Acquisition of Significant Ownership Position in NextGen Healthcare and Partners with Thoma Bravo…
New resource helps healthcare providers improve branded communication, ensure HIPAA compliance, and boost patient engagement…
TEMPE, Ariz., June 6, 2025 /PRNewswire/ -- Economic activity in the hospital subsector expanded in…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="173px" width="400px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
